Crossmark

Inhibitor screening identifies Entecavir as a promising candidate targeting human eIF4E to block cap-dependent translation in cancer: an integrated in silico and in vitro study

Crossref DOI link: https://doi.org/10.1007/s10822-025-00759-1

Published Online: 2026-01-10

Published Print: 2026-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Nagasubramanian, Kishore

Vincent, Preethi

Gupta, Krishna Kant

Chandran, Sam Aldrin
Funding

Funding for this research was provided by:

SASTRA-TRR (SCBT-4-01072025)
License Information

Text and Data Mining valid from 2026-01-10

Version of Record valid from 2026-01-10
More Information

Article History

Received: 14 August 2025

Accepted: 31 December 2025

First Online: 10 January 2026

Declarations

:

: The authors declare no competing interests.

: Not applicable.

: Not applicable.

: Not applicable.

: During the writing of this manuscript, the author(s) used ChatGPT to refine the language and correct grammatical errors. After using this tool/service, the author(s) reviewed and edited the content as needed and take(s) full responsibility for the content of the publication.

Document is current

Any future updates will be listed below